Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Therapeutic Scoliosis-Specific Exercises for a Child With Spinal Muscular Atrophy: A Case Report
Cara Yochai, Rafael Rodriguez‐Torres, Rebekah Wallach, et al.
Pediatric Physical Therapy (2025)
Closed Access | Times Cited: 1
Rehabilitation practices for childhood spinal muscular atrophy
Patricia Mortenson, Julia Cielecka, Emma Harrison, et al.
Disability and Rehabilitation (2025), pp. 1-10
Closed Access | Times Cited: 1
Nusinersen therapy changed the natural course of spinal muscular atrophy type 1: What about spine and hip?
Niyazi Erdem Yaşar, Güzelali Özdemir, Elif Uzun Ata, et al.
Journal of Children s Orthopaedics (2024) Vol. 18, Iss. 3, pp. 322-330
Open Access | Times Cited: 7
A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders
Besarte Vrellaku, I. S. M. Hassan, Rebecca Howitt, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3220-3259
Open Access | Times Cited: 6
Spinal Muscular Atrophy Scoliosis in the Era of Background Therapies—A Review of the Literature
Fred Ruythooren, Pierre Moens
Journal of Clinical Medicine (2024) Vol. 13, Iss. 12, pp. 3467-3467
Open Access | Times Cited: 5
Scoliosis in spinal muscular atrophy in the era of disease-modifying therapy: a scoping review
Martina Gnazzo, Giulia Pisanò, Benedetta Piccolo, et al.
Neurological Sciences (2025)
Open Access
Effect of nusinersen after 3 years of treatment in 57 young children with SMA in terms of SMN2 copy number or type
Frédérique Audic, Sonia M. Dubois, Julien Durigneux, et al.
Archives de Pédiatrie (2023) Vol. 31, Iss. 2, pp. 117-123
Closed Access | Times Cited: 8
Advances and Challenges in Gene Therapy for Neurodegenerative Diseases: A Systematic Review
Nerea García-González, Jaime Gonçalves-Sánchez, Ricardo Gómez‐Nieto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12485-12485
Open Access | Times Cited: 2
Safety and efficacy of growth-friendly instrumentation for early-onset scoliosis in patients with spinal muscular atrophy type 1 in the disease-modifying treatment era
Rıza Mert Çetik, Dror Ovadia, Kiril Mladenov, et al.
Journal of Children s Orthopaedics (2023) Vol. 18, Iss. 1, pp. 26-32
Open Access | Times Cited: 6
Unraveling innovative treatments for spinal muscular atrophy: a brief review
Sadia Naseem, Shireen Fatima, D. Navya Sai Vijaya
International Journal of Community Medicine and Public Health (2024) Vol. 11, Iss. 9, pp. 3745-3750
Open Access | Times Cited: 1
Gene therapy for spinal muscular atrophy: perspectives on the possibility of optimizing SMN1 delivery to correct all neurological and systemic perturbations
Sharon J. Brown, Rafael J. Yáñez‐Muñoz, Heidi R. Fuller
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 2011-2012
Open Access
Spinal presentations in children with Spinal Muscular Atrophy type 1 following Gene Therapy treatment with onasemnogene abeparvovec – the SMA REACH UK network experience
Amy Wolfe, Jennie Sheehan, Alex Schofield, et al.
Neuromuscular Disorders (2024) Vol. 44, pp. 104451-104451
Closed Access
Utility of postoperative laboratory testing after posterior spinal fusion for adolescent idiopathic scoliosis
David S. Liu, Alexander R. Farid, Gabriel S. Linden, et al.
Spine Deformity (2023) Vol. 12, Iss. 2, pp. 375-381
Closed Access
Page 1

Scroll to top